Critical Analysis: Eurofins Scient (OTCMKTS:ERFSF) and Teladoc Health (NYSE:TDOC)

Teladoc Health (NYSE:TDOC) and Eurofins Scient (OTCMKTS:ERFSF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, institutional ownership and valuation.

Valuation and Earnings

This table compares Teladoc Health and Eurofins Scient”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53 billion	0.46	-$200.32 million	($0.97)	-6.60
Eurofins Scient	$8.25 billion	1.62	$537.29 million	N/A	N/A

Eurofins Scient has higher revenue and earnings than Teladoc Health.

Risk and Volatility

Teladoc Health has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Comparatively, Eurofins Scient has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500.

Insider & Institutional Ownership

76.8% of Teladoc Health shares are held by institutional investors. 0.7% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and price targets for Teladoc Health and Eurofins Scient, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1	12	5	0	2.22
Eurofins Scient	0	2	1	0	2.33

Teladoc Health presently has a consensus target price of $7.53, suggesting a potential upside of 17.58%. Given Teladoc Health’s higher possible upside, equities research analysts clearly believe Teladoc Health is more favorable than Eurofins Scient.

Profitability

This table compares Teladoc Health and Eurofins Scient’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.81%	-11.45%	-5.54%
Eurofins Scient	N/A	N/A	N/A

Summary

Eurofins Scient beats Teladoc Health on 7 of the 12 factors compared between the two stocks.

About Teladoc Health

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

About Eurofins Scient

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.